Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Asym. Unit - sites
(-)Biological Unit 1
(-)Biol. Unit 1 - sites
(-)Biological Unit 2
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Asym. Unit - sites
Asym. Unit - sites  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biol. Unit 1 - sites
Biol. Unit 1 - sites  (Jmol Viewer)
Image Biological Unit 2
Biological Unit 2  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF VEGF-C IN COMPLEX WITH DOMAINS 2 AND 3 OF VEGFR2
 
Authors :  V. M. Leppanen, A. E. Prota, M. Jeltsch, A. Anisimov, N. Kalkkinen, T. Strandin, H. Lankinen, A. Goldman, K. Ballmer-Hofer, K. Alitalo
Date :  08 Jan 10  (Deposition) - 09 Mar 10  (Release) - 11 Jan 12  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.70
Chains :  Asym. Unit :  A,B,C,D,L,M,N,O
Biol. Unit 1:  A,B,M,N  (1x)
Biol. Unit 2:  C,D,L,O  (1x)
Keywords :  Hormone-Signaling Protein Complex, Angiogenesis, Glycoprotein, Host-Virus Interaction, Membrane, Receptor, Lymphangiogenesis, Immunoglobulin Domain, Developmental Protein, Transmembrane, Phosphoprotein, Disulfide Bond, Mitogen (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  V. M. Leppanen, A. E. Prota, M. Jeltsch, A. Anisimov, N. Kalkkinen, T. Strandin, H. Lankinen, A. Goldman, K. Ballmer-Hofer, K. Alitalo
Structural Determinants Of Growth Factor Binding And Specificity By Vegf Receptor 2.
Proc. Natl. Acad. Sci. Usa V. 107 2425 2010
PubMed-ID: 20145116  |  Reference-DOI: 10.1073/PNAS.0914318107

(-) Compounds

Molecule 1 - VASCULAR ENDOTHELIAL GROWTH FACTOR C
    ChainsA, B, C, D
    EngineeredYES
    Expression SystemSPODOPTERA FRUGIPERDA
    Expression System Cell LineSF9
    Expression System CommonFALL ARMYWORM
    Expression System PlasmidPFASTBAC
    Expression System Taxid7108
    Expression System Vector TypeBACULOVIRUS
    FragmentVEGF HOMOLOGY DOMAIN, RESIDUES 112-215
    MutationYES
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymVEGF-C, VASCULAR ENDOTHELIAL GROWTH FACTOR-RELATED PROTEIN, VRP, FLT4 LIGAND, FLT4-L
 
Molecule 2 - VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2
    ChainsL, M, N, O
    EngineeredYES
    Expression SystemSPODOPTERA FRUGIPERDA
    Expression System Cell LineSF9
    Expression System CommonFALL ARMYWORM
    Expression System PlasmidPFASTBAC
    Expression System Taxid7108
    Expression System Vector TypeBACULOVIRUS
    FragmentIG-LIKE DOMAINS 2 AND 3, RESIDUES 120-326
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymVEGF RECEPTOR 2, VEGFR-2, KINASE INSERT DOMAIN RECEPTOR, PROTEIN-TYROSINE KINASE RECEPTOR FLK-1, CD309, FLK-1

 Structural Features

(-) Chains, Units

  12345678
Asymmetric Unit ABCDLMNO
Biological Unit 1 (1x)AB   MN 
Biological Unit 2 (1x)  CDL  O

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (3, 44)

Asymmetric Unit (3, 44)
No.NameCountTypeFull Name
1BMA9Ligand/IonBETA-D-MANNOSE
2CS2Ligand/IonCESIUM ION
3NAG33Ligand/IonN-ACETYL-D-GLUCOSAMINE
Biological Unit 1 (2, 21)
No.NameCountTypeFull Name
1BMA5Ligand/IonBETA-D-MANNOSE
2CS-1Ligand/IonCESIUM ION
3NAG16Ligand/IonN-ACETYL-D-GLUCOSAMINE
Biological Unit 2 (2, 21)
No.NameCountTypeFull Name
1BMA4Ligand/IonBETA-D-MANNOSE
2CS-1Ligand/IonCESIUM ION
3NAG17Ligand/IonN-ACETYL-D-GLUCOSAMINE

(-) Sites  (22, 22)

Asymmetric Unit (22, 22)
No.NameEvidenceResiduesDescription
01AC1SOFTWAREASN L:143 , ARG L:176BINDING SITE FOR RESIDUE NAG L2401
02AC2SOFTWARELYS L:317 , ASN L:318 , HOH L:2031 , HOH L:2032BINDING SITE FOR RESIDUE NAG L2701
03AC3SOFTWAREASN N:143BINDING SITE FOR RESIDUE NAG N1401
04AC4SOFTWARENAG C:501 , SER N:229 , ASN N:245 , LEU N:289 , HOH N:2032BINDING SITE FOR RESIDUE NAG N1601
05AC5SOFTWAREGLU M:326 , LYS O:142 , ASN O:143 , TYR O:190BINDING SITE FOR RESIDUE NAG O2001
06AC6SOFTWAREASN O:158 , LYS O:203BINDING SITE FOR RESIDUE NAG O2101
07AC7SOFTWAREASP O:225 , VAL O:226 , VAL O:227 , ASN O:318BINDING SITE FOR RESIDUE NAG O2301
08AC8SOFTWAREGLU A:169 , THR B:148BINDING SITE FOR RESIDUE CS B1215
09AC9SOFTWARETHR C:150BINDING SITE FOR RESIDUE CS C1216
10BC1SOFTWAREASN A:175 , THR A:176 , SER A:177 , THR A:178 , TYR A:180 , ALA A:204 , HIS A:206 , HOH A:2012BINDING SITE FOR CHAIN A OF SUGAR BOUND TO ASN A 175 RESIDUES 400 TO 402
11BC2SOFTWAREPRO A:133 , TYR A:160 , SER A:179 , LEU A:181 , ASN A:205 , HIS A:206 , THR A:207 , HOH A:2013BINDING SITE FOR CHAIN A OF SUGAR BOUND TO ASN A 205 RESIDUES 500 TO 502
12BC3SOFTWAREASN B:175 , THR B:176 , SER B:177 , THR B:178 , TYR B:180 , ALA B:204 , HIS B:206BINDING SITE FOR CHAIN B OF SUGAR BOUND TO ASN B 175 RESIDUES 400 TO 402
13BC4SOFTWARETYR B:160 , LEU B:181 , ASN B:205 , HIS B:206 , HOH B:2009 , HOH B:2011 , NAG O:2201 , NAG O:2202BINDING SITE FOR CHAIN B OF SUGAR BOUND TO ASN B 205 RESIDUES 500 TO 502
14BC5SOFTWAREASN C:175 , THR C:176 , SER C:177 , THR C:178 , TYR C:180 , ALA C:204 , HIS C:206 , GLU N:235 , SER N:237BINDING SITE FOR CHAIN C OF SUGAR BOUND TO ASN C 175 RESIDUES 400 TO 402
15BC6SOFTWAREPRO C:133 , TYR C:160 , LEU C:181 , ASN C:205 , HIS C:206 , THR C:207 , HOH C:2031 , HOH C:2032 , PRO N:230 , NAG N:1601BINDING SITE FOR CHAIN C OF SUGAR BOUND TO ASN C 205 RESIDUES 500 TO 502
16BC7SOFTWAREASN D:175 , THR D:176 , SER D:177 , THR D:178 , TYR D:180 , ALA D:204 , HIS D:206 , HOH D:2019BINDING SITE FOR CHAIN D OF SUGAR BOUND TO ASN D 175 RESIDUES 400 TO 402
17BC8SOFTWAREPRO D:133 , TYR D:160 , ASN D:205 , HIS D:206 , THR D:207BINDING SITE FOR CHAIN D OF SUGAR BOUND TO ASN D 205 RESIDUES 500 TO 502
18BC9SOFTWARESER L:229 , ASN L:245 , HOH L:2030BINDING SITE FOR CHAIN L OF SUGAR BOUND TO ASN L 245 RESIDUES 2601 TO 2602
19CC1SOFTWARESER M:229 , ASN M:245 , ARG M:275BINDING SITE FOR CHAIN M OF SUGAR BOUND TO ASN M 245 RESIDUES 1201 TO 1202
20CC2SOFTWAREVAL M:226 , SER M:231 , ASN M:318BINDING SITE FOR CHAIN M OF SUGAR BOUND TO ASN M 318 RESIDUES 1301 TO 1303
21CC3SOFTWAREASP N:225 , VAL N:226 , LYS N:317 , ASN N:318 , HOH N:2012 , HOH N:2033 , HOH N:2034 , HOH N:2035BINDING SITE FOR CHAIN N OF SUGAR BOUND TO ASN N 318 RESIDUES 1701 TO 1702
22CC4SOFTWAREBMA B:502 , SER O:229 , ASN O:245 , LEU O:289BINDING SITE FOR CHAIN O OF SUGAR BOUND TO ASN O 245 RESIDUES 2201 TO 2202

(-) SS Bonds  (24, 24)

Asymmetric Unit
No.Residues
1A:131 -A:173
2A:156 -B:165
3A:162 -A:209
4A:165 -B:156
5A:166 -A:211
6B:131 -B:173
7B:162 -B:209
8B:166 -B:211
9C:131 -C:173
10C:156 -D:165
11C:162 -C:209
12C:165 -D:156
13C:166 -C:211
14D:131 -D:173
15D:162 -D:209
16D:166 -D:211
17L:150 -L:200
18L:246 -L:307
19M:150 -M:200
20M:246 -M:307
21N:150 -N:200
22N:246 -N:307
23O:150 -O:200
24O:246 -O:307

(-) Cis Peptide Bonds  (24, 24)

Asymmetric Unit
No.Residues
1Lys A:153 -Pro A:154
2Val A:190 -Pro A:191
3Lys B:153 -Pro B:154
4Val B:190 -Pro B:191
5Lys C:153 -Pro C:154
6Val C:190 -Pro C:191
7Lys D:153 -Pro D:154
8Val D:190 -Pro D:191
9Ile L:138 -Thr L:139
10Arg L:164 -Tyr L:165
11Tyr L:165 -Pro L:166
12Ser L:229 -Pro L:230
13Arg M:164 -Tyr M:165
14Tyr M:165 -Pro M:166
15Ser M:229 -Pro M:230
16Arg N:164 -Tyr N:165
17Tyr N:165 -Pro N:166
18Ser N:229 -Pro N:230
19Gln N:280 -Ser N:281
20Ser O:123 -Pro O:124
21Arg O:164 -Tyr O:165
22Tyr O:165 -Pro O:166
23Val O:219 -Gly O:220
24Ser O:229 -Pro O:230

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (5, 20)

Asymmetric Unit (5, 20)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_042054V136MVGFR2_HUMANPolymorphism35636987L/M/N/OV136M
2UniProtVAR_042055A248GVGFR2_HUMANUnclassified  ---L/M/N/OA248G
3UniProtVAR_036126R275LVGFR2_HUMANUnclassified  ---L/M/N/OR275L
4CancerSNPVAR_VGFR2_HUMAN_CCDS3497_1_01 *R275LVGFR2_HUMANDisease (Colorectal cancer)  ---L/M/N/OR275L
5UniProtVAR_022071V297IVGFR2_HUMANPolymorphism2305948L/M/N/OV297I
   * ID not provided by source

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 1 (5, 10)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_042054V136MVGFR2_HUMANPolymorphism35636987M/NV136M
2UniProtVAR_042055A248GVGFR2_HUMANUnclassified  ---M/NA248G
3UniProtVAR_036126R275LVGFR2_HUMANUnclassified  ---M/NR275L
4CancerSNPVAR_VGFR2_HUMAN_CCDS3497_1_01 *R275LVGFR2_HUMANDisease (Colorectal cancer)  ---M/NR275L
5UniProtVAR_022071V297IVGFR2_HUMANPolymorphism2305948M/NV297I
   * ID not provided by source

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 2 (5, 10)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_042054V136MVGFR2_HUMANPolymorphism35636987L/OV136M
2UniProtVAR_042055A248GVGFR2_HUMANUnclassified  ---L/OA248G
3UniProtVAR_036126R275LVGFR2_HUMANUnclassified  ---L/OR275L
4CancerSNPVAR_VGFR2_HUMAN_CCDS3497_1_01 *R275LVGFR2_HUMANDisease (Colorectal cancer)  ---L/OR275L
5UniProtVAR_022071V297IVGFR2_HUMANPolymorphism2305948L/OV297I
   * ID not provided by source

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (2, 7)

Asymmetric Unit (2, 7)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PDGF_2PS50278 Platelet-derived growth factor (PDGF) family profile.VEGFC_HUMAN117-216
 
 
  3A:117-213
B:117-214
D:117-215
2PDGF_1PS00249 Platelet-derived growth factor (PDGF) family signature.VEGFC_HUMAN154-166
 
 
 
  4A:154-166
B:154-166
C:154-166
D:154-166
Biological Unit 1 (2, 4)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PDGF_2PS50278 Platelet-derived growth factor (PDGF) family profile.VEGFC_HUMAN117-216
 
 
  2A:117-213
B:117-214
-
2PDGF_1PS00249 Platelet-derived growth factor (PDGF) family signature.VEGFC_HUMAN154-166
 
 
 
  2A:154-166
B:154-166
-
-
Biological Unit 2 (2, 3)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PDGF_2PS50278 Platelet-derived growth factor (PDGF) family profile.VEGFC_HUMAN117-216
 
 
  1-
-
D:117-215
2PDGF_1PS00249 Platelet-derived growth factor (PDGF) family signature.VEGFC_HUMAN154-166
 
 
 
  2-
-
C:154-166
D:154-166

(-) Exons   (5, 19)

Asymmetric Unit (5, 19)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1aENST000002639231aENSE00001171700chr4:55991756-55991394363VGFR2_HUMAN1-23230--
1.2ENST000002639232ENSE00000716050chr4:55987357-5598726494VGFR2_HUMAN23-54320--
1.3ENST000002639233ENSE00000716047chr4:55984967-55984771197VGFR2_HUMAN54-120670--
1.4ENST000002639234ENSE00000716045chr4:55981578-55981448131VGFR2_HUMAN120-163444L:123-163 (gaps)
M:134-163
N:124-163 (gaps)
O:123-163 (gaps)
41
30
40
41
1.5ENST000002639235ENSE00000716043chr4:55981209-55981041169VGFR2_HUMAN164-220574L:164-220 (gaps)
M:164-220 (gaps)
N:164-220
O:164-220
57
57
57
57
1.6ENST000002639236ENSE00000716040chr4:55980432-55980293140VGFR2_HUMAN220-266474L:220-266
M:220-264
N:220-265
O:220-263
47
45
46
44
1.7ENST000002639237ENSE00000716038chr4:55979648-55979471178VGFR2_HUMAN267-326604L:267-326
M:269-326 (gaps)
N:270-326
O:269-325 (gaps)
60
58
57
57
1.8ENST000002639238ENSE00000716036chr4:55976935-55976821115VGFR2_HUMAN326-364393L:326-326
M:326-326
N:326-326
-
1
1
1
-
1.9ENST000002639239ENSE00000580228chr4:55976733-55976570164VGFR2_HUMAN364-419560--
1.10ENST0000026392310ENSE00000716032chr4:55974060-55973904157VGFR2_HUMAN419-471530--
1.11ENST0000026392311ENSE00000716030chr4:55972977-55972854124VGFR2_HUMAN471-512420--
1.12ENST0000026392312ENSE00000716029chr4:55972107-55971999109VGFR2_HUMAN513-549370--
1.13aENST0000026392313aENSE00001074496chr4:55971151-55970810342VGFR2_HUMAN549-6631150--
1.14ENST0000026392314ENSE00000716025chr4:55968675-55968529147VGFR2_HUMAN663-712500--
1.15ENST0000026392315ENSE00000716023chr4:55968195-55968064132VGFR2_HUMAN712-756450--
1.16ENST0000026392316ENSE00000716022chr4:55964970-55964864107VGFR2_HUMAN756-791360--
1.17ENST0000026392317ENSE00000716020chr4:55964439-55964304136VGFR2_HUMAN792-837460--
1.18ENST0000026392318ENSE00000716018chr4:55963933-55963829105VGFR2_HUMAN837-872360--
1.19bENST0000026392319bENSE00001312000chr4:55962509-55962396114VGFR2_HUMAN872-910390--
1.20ENST0000026392320ENSE00000716016chr4:55961832-5596174489VGFR2_HUMAN910-939300--
1.21bENST0000026392321bENSE00000716015chr4:55961122-55960969154VGFR2_HUMAN940-991520--
1.22ENST0000026392322ENSE00000877921chr4:55958881-5595878498VGFR2_HUMAN991-1023330--
1.23ENST0000026392323ENSE00001608690chr4:55956245-55956123123VGFR2_HUMAN1024-1064410--
1.24ENST0000026392324ENSE00000877919chr4:55955969-55955858112VGFR2_HUMAN1065-1102380--
1.25ENST0000026392325ENSE00000877918chr4:55955640-55955541100VGFR2_HUMAN1102-1135340--
1.26ENST0000026392326ENSE00000877917chr4:55955140-55955035106VGFR2_HUMAN1135-1170360--
1.27ENST0000026392327ENSE00000877916chr4:55953925-55953774152VGFR2_HUMAN1171-1221510--
1.28ENST0000026392328ENSE00000877915chr4:55948802-55948703100VGFR2_HUMAN1221-1254340--
1.29ENST0000026392329ENSE00001148006chr4:55948208-5594812386VGFR2_HUMAN1255-1283290--
1.30ENST0000026392330ENSE00001171693chr4:55946330-559446441687VGFR2_HUMAN1283-1356740--

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:98
 aligned with VEGFC_HUMAN | P49767 from UniProtKB/Swiss-Prot  Length:419

    Alignment length:98
                                   125       135       145       155       165       175       185       195       205        
          VEGFC_HUMAN   116 TEILKSIDNEWRKTQCMPREVCIDVGKEFGVATNTFFKPPCVSVYRCGGCCNSEGLQCMNTSTSYLSKTLFEITVPLSQGPKPVTISFANHTSCRCMS 213
               SCOP domains d2x1wa_ A: automated matches                                                                       SCOP domains
               CATH domains 2x1wA00 A:116-213 Cystine-knot cytokines                                                           CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author hhhhhhhhhhhhhhh.eeeeeeee...........eee..eeeeeeee........eeeeeeeeeeeeeeeee........eeeeeeeeeeeeeeee. Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (1) -PDGF_2  PDB: A:117-213 UniProt: 117-216                                                           PROSITE (1)
                PROSITE (2) --------------------------------------PDGF_1       ----------------------------------------------- PROSITE (2)
                 Transcript -------------------------------------------------------------------------------------------------- Transcript
                 2x1w A 116 TEILKSIDNEWRKTQCMPREVAIDVGKEFGVATNTFFKPPCVSVYRCGGCCNSEGLQCMNTSTSYLSKTLFEITVPLSQGPKPVTISFANHTSCRCMS 213
                                   125       135       145       155       165       175       185       195       205        

Chain B from PDB  Type:PROTEIN  Length:98
 aligned with VEGFC_HUMAN | P49767 from UniProtKB/Swiss-Prot  Length:419

    Alignment length:98
                                   126       136       146       156       166       176       186       196       206        
          VEGFC_HUMAN   117 EILKSIDNEWRKTQCMPREVCIDVGKEFGVATNTFFKPPCVSVYRCGGCCNSEGLQCMNTSTSYLSKTLFEITVPLSQGPKPVTISFANHTSCRCMSK 214
               SCOP domains d2x1wb_ B: automated matches                                                                       SCOP domains
               CATH domains 2x1wB00 B:117-214 Cystine-knot cytokines                                                           CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..hhhhhhhhhhhh.eeeeeeeehhhhh.....eeee..eeeeeeee.......eeeeeeeeeeeeeeeeeee.......eeeeeeeeeeeeeeeee. Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (1) PDGF_2  PDB: B:117-214 UniProt: 117-216                                                            PROSITE (1)
                PROSITE (2) -------------------------------------PDGF_1       ------------------------------------------------ PROSITE (2)
                 Transcript -------------------------------------------------------------------------------------------------- Transcript
                 2x1w B 117 EILKSIDNEWRKTQCMPREVAIDVGKEFGVATNTFFKPPCVSVYRCGGCCNSEGLQCMNTSTSYLSKTLFEITVPLSQGPKPVTISFANHTSCRCMSK 214
                                   126       136       146       156       166       176       186       196       206        

Chain C from PDB  Type:PROTEIN  Length:97
 aligned with VEGFC_HUMAN | P49767 from UniProtKB/Swiss-Prot  Length:419

    Alignment length:97
                                   128       138       148       158       168       178       188       198       208       
          VEGFC_HUMAN   119 LKSIDNEWRKTQCMPREVCIDVGKEFGVATNTFFKPPCVSVYRCGGCCNSEGLQCMNTSTSYLSKTLFEITVPLSQGPKPVTISFANHTSCRCMSKL 215
               SCOP domains d2x1wc_ C: automated matches                                                                      SCOP domains
               CATH domains 2x1wC00 C:119-215 Cystine-knot cytokines                                                          CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author hhhhhhhhhhhh.eeeeeeeehhhhh.....eeee..eeeeeeee.......eeeeeeeeeeeeeeeeeee.......eeeeeeeeeeeeeeeee.. Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (1) PDGF_2  PDB: - UniProt: 117-216                                                                   PROSITE (1)
                PROSITE (2) -----------------------------------PDGF_1       ------------------------------------------------- PROSITE (2)
                 Transcript ------------------------------------------------------------------------------------------------- Transcript
                 2x1w C 119 LKSIDNEWRKTQCMPREVAIDVGKEFGVATNTFFKPPCVSVYRCGGCCNSEGLQCMNTSTSYLSKTLFEITVPLSQGPKPVTISFANHTSCRCMSKL 215
                                   128       138       148       158       168       178       188       198       208       

Chain D from PDB  Type:PROTEIN  Length:99
 aligned with VEGFC_HUMAN | P49767 from UniProtKB/Swiss-Prot  Length:419

    Alignment length:99
                                   126       136       146       156       166       176       186       196       206         
          VEGFC_HUMAN   117 EILKSIDNEWRKTQCMPREVCIDVGKEFGVATNTFFKPPCVSVYRCGGCCNSEGLQCMNTSTSYLSKTLFEITVPLSQGPKPVTISFANHTSCRCMSKL 215
               SCOP domains d2x1wd_ D: automated matches                                                                        SCOP domains
               CATH domains 2x1wD00 D:117-215 Cystine-knot cytokines                                                            CATH domains
           Pfam domains (1) --------------PDGF-2x1wD01 D:131-211                                                           ---- Pfam domains (1)
           Pfam domains (2) --------------PDGF-2x1wD02 D:131-211                                                           ---- Pfam domains (2)
           Pfam domains (3) --------------PDGF-2x1wD03 D:131-211                                                           ---- Pfam domains (3)
           Pfam domains (4) --------------PDGF-2x1wD04 D:131-211                                                           ---- Pfam domains (4)
         Sec.struct. author hhhhhhhhhhhhhh.eeeeeeeehhhhh.....eeee..eeeeeeee.......eeeeeeeeeeeeeeeeeee.......eeeeeeeeeeeeeeeee.. Sec.struct. author
                 SAPs(SNPs) --------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (1) PDGF_2  PDB: D:117-215 UniProt: 117-216                                                             PROSITE (1)
                PROSITE (2) -------------------------------------PDGF_1       ------------------------------------------------- PROSITE (2)
                 Transcript --------------------------------------------------------------------------------------------------- Transcript
                 2x1w D 117 EILKSIDNEWRKTQCMPREVAIDVGKEFGVATNTFFKPPCVSVYRCGGCCNSEGLQCMNTSTSYLSKTLFEITVPLSQGPKPVTISFANHTSCRCMSKL 215
                                   126       136       146       156       166       176       186       196       206         

Chain L from PDB  Type:PROTEIN  Length:196
 aligned with VGFR2_HUMAN | P35968 from UniProtKB/Swiss-Prot  Length:1356

    Alignment length:204
                                   132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322    
          VGFR2_HUMAN   123 SPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHE 326
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author ......----.eeeee......eeee..........eeeeee...eee.......eee...eeeee.hhh....eeeeee.----.ee...eeeee....eeeeeee....eeee....eeeeeeeee......eeeee........eeeeeeee........eeeeeeeee...hhhhheeeeeeee....eeeeeeeeeee. Sec.struct. author
             SAPs(SNPs) (1) -------------M---------------------------------------------------------------------------------------------------------------G--------------------------L---------------------I----------------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------------------------------------------------------------------------------------------------------------------------------------------------L--------------------------------------------------- SAPs(SNPs) (2)
                    PROSITE ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ PROSITE
           Transcript 1 (1) Exon 1.4  PDB: L:123-163 (gaps)          Exon 1.5  PDB: L:164-220 (gaps) UniProt: 164-220         ----------------------------------------------Exon 1.7  PDB: L:267-326 UniProt: 267-326                    Transcript 1 (1)
           Transcript 1 (2) -------------------------------------------------------------------------------------------------Exon 1.6  PDB: L:220-266 UniProt: 220-266      -----------------------------------------------------------1 Transcript 1 (2)
                 2x1w L 123 SPFIAS----HGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAK----SYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHE 326
                                 |   -|      142       152       162       172       182       192       202|    | 212       222       232       242       252       262       272       282       292       302       312       322    
                               128  133                                                                   203  208                                                                                                                      

Chain M from PDB  Type:PROTEIN  Length:179
 aligned with VGFR2_HUMAN | P35968 from UniProtKB/Swiss-Prot  Length:1356

    Alignment length:193
                                   143       153       163       173       183       193       203       213       223       233       243       253       263       273       283       293       303       313       323   
          VGFR2_HUMAN   134 GVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHE 326
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .eeee......eeee...........eeeee...eee.......ee.....eeee.hhh....eeeee.-------....eeeee....eeeeeee.....eee....eeeeeeeeee.....eeeee...----.eeeeeeee..---..eeeeeeeeee...hhhhheeeeeeee....eeeeeeeeeee. Sec.struct. author
             SAPs(SNPs) (1) --M---------------------------------------------------------------------------------------------------------------G--------------------------L---------------------I----------------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ---------------------------------------------------------------------------------------------------------------------------------------------L--------------------------------------------------- SAPs(SNPs) (2)
                    PROSITE ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.4  PDB: M:134-163      Exon 1.5  PDB: M:164-220 (gaps) UniProt: 164-220         ----------------------------------------------Exon 1.7  PDB: M:269-326 (gaps) UniProt: 267-326             Transcript 1 (1)
           Transcript 1 (2) --------------------------------------------------------------------------------------Exon 1.6  PDB: M:220-264 UniProt: 220-266      -----------------------------------------------------------1 Transcript 1 (2)
                 2x1w M 134 GVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEA-------QSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPS----HKKLVNRDLKT---SEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHE 326
                                   143       153       163       173       183       193        |-      |213       223       233       243       253       263|    | 273     | 283       293       303       313       323   
                                                                                              202     210                                                   264  269       279 283                                           

Chain N from PDB  Type:PROTEIN  Length:194
 aligned with VGFR2_HUMAN | P35968 from UniProtKB/Swiss-Prot  Length:1356

    Alignment length:203
                                   133       143       153       163       173       183       193       203       213       223       233       243       253       263       273       283       293       303       313       323   
          VGFR2_HUMAN   124 PFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHE 326
               SCOP domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ...-----..eeeee......eeee..........eeeeee...eee.......ee.....eeee.hhh....eeeeeeee..eeee...eeeee....eeeeeee.....eee....eeeeeeeeee.....eeeee....----.eeeeeee.......eeeeeeeeee...hhhhheeeeeeee....eeeeeeeeeee. Sec.struct. author
             SAPs(SNPs) (1) ------------M---------------------------------------------------------------------------------------------------------------G--------------------------L---------------------I----------------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) -------------------------------------------------------------------------------------------------------------------------------------------------------L--------------------------------------------------- SAPs(SNPs) (2)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.4  PDB: N:124-163 (gaps)         Exon 1.5  PDB: N:164-220 UniProt: 164-220                ----------------------------------------------Exon 1.7  PDB: N:270-326 UniProt: 267-326 [INCOMPLETE]       Transcript 1 (1)
           Transcript 1 (2) ------------------------------------------------------------------------------------------------Exon 1.6  PDB: N:220-265 UniProt: 220-266      -----------------------------------------------------------1 Transcript 1 (2)
                 2x1w N 124 PFI-----QHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSS----KKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHE 326
                              |    133       143       153       163       173       183       193       203       213       223       233       243       253       263 |    |273       283       293       303       313       323   
                            126   132                                                                                                                                  265  270                                                        

Chain O from PDB  Type:PROTEIN  Length:193
 aligned with VGFR2_HUMAN | P35968 from UniProtKB/Swiss-Prot  Length:1356

    Alignment length:203
                                   132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322   
          VGFR2_HUMAN   123 SPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVH 325
               SCOP domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
           Pfam domains (1) -----    ---------------------------------------------------------------------------------------------V-set-2x1wO01 O:225-324                                                                             - Pfam domains (1)
           Pfam domains (2) -----    ---------------------------------------------------------------------------------------------V-set-2x1wO02 O:225-324                                                                             - Pfam domains (2)
           Pfam domains (3) -----    ---------------------------------------------------------------------------------------------V-set-2x1wO03 O:225-324                                                                             - Pfam domains (3)
           Pfam domains (4) -----    ---------------------------------------------------------------------------------------------V-set-2x1wO04 O:225-324                                                                             - Pfam domains (4)
         Sec.struct. author .....----.eeeeee......eeee.........eeeeeee...eee.......eee...eeeee.hhh....eeeeeee....eee..eeeeee....eeeeeee....eeee....eeeeeeeee......eeeee..-----.eeeeeeee...-....eeeeeeeee...hhhhheeeeeeee....eeeeeeeeeee Sec.struct. author
             SAPs(SNPs) (1) -------------M---------------------------------------------------------------------------------------------------------------G--------------------------L---------------------I---------------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------------------------------------------------------------------------------------------------------------------------------------------------L-------------------------------------------------- SAPs(SNPs) (2)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.4  PDB: O:123-163 (gaps)          Exon 1.5  PDB: O:164-220 UniProt: 164-220                ----------------------------------------------Exon 1.7  PDB: O:269-325 (gaps) UniProt: 267-326            Transcript 1 (1)
           Transcript 1 (2) -------------------------------------------------------------------------------------------------Exon 1.6  PDB: O:220-263 UniProt: 220-266      ----------------------------------------------------------- Transcript 1 (2)
                 2x1w O 123 SPFIA----QHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYP-----HKKLVNRDLKTQ-GSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVH 325
                                |  132       142       152       162       172       182       192       202       212       222       232       242       252       262|     |272       282       292       302       312       322   
                              127  132                                                                                                                                263   269        280 |                                           
                                                                                                                                                                                         282                                           

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (1, 4)

Asymmetric Unit

(-) CATH Domains  (1, 4)

Asymmetric Unit
(-)
Class: Mainly Beta (13760)

(-) Pfam Domains  (2, 8)

Asymmetric Unit
(-)
Family: PDGF (19)
1aPDGF-2x1wD01D:131-211
1bPDGF-2x1wD02D:131-211
1cPDGF-2x1wD03D:131-211
1dPDGF-2x1wD04D:131-211
(-)
Clan: Ig (577)
(-)
Family: V-set (144)
2aV-set-2x1wO01O:225-324
2bV-set-2x1wO02O:225-324
2cV-set-2x1wO03O:225-324
2dV-set-2x1wO04O:225-324

(-) Gene Ontology  (94, 103)

Asymmetric Unit(hide GO term definitions)
Chain A,B,C,D   (VEGFC_HUMAN | P49767)
molecular function
    GO:0042056    chemoattractant activity    Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal.
    GO:0008083    growth factor activity    The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0043185    vascular endothelial growth factor receptor 3 binding    Interacting selectively and non-covalently with vascular endothelial growth factor receptor 3.
biological process
    GO:0001525    angiogenesis    Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
    GO:0009887    animal organ morphogenesis    Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
    GO:0030154    cell differentiation    The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
    GO:0050930    induction of positive chemotaxis    Any process that initiates the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
    GO:0016331    morphogenesis of embryonic epithelium    The process in which the anatomical structures of embryonic epithelia are generated and organized.
    GO:0007275    multicellular organism development    The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
    GO:0045776    negative regulation of blood pressure    Any process in which the force of blood traveling through the circulatory system is decreased.
    GO:0008285    negative regulation of cell proliferation    Any process that stops, prevents or reduces the rate or extent of cell proliferation.
    GO:0002576    platelet degranulation    The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
    GO:0050918    positive chemotaxis    The directed movement of a motile cell or organism towards a higher concentration of a chemical.
    GO:0045766    positive regulation of angiogenesis    Any process that activates or increases angiogenesis.
    GO:0043536    positive regulation of blood vessel endothelial cell migration    Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
    GO:0051781    positive regulation of cell division    Any process that activates or increases the frequency, rate or extent of cell division.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:0001954    positive regulation of cell-matrix adhesion    Any process that activates or increases the rate or extent of cell adhesion to an extracellular matrix.
    GO:0050679    positive regulation of epithelial cell proliferation    Any process that activates or increases the rate or extent of epithelial cell proliferation.
    GO:1901492    positive regulation of lymphangiogenesis    Any process that activates or increases the frequency, rate or extent of lymphangiogenesis.
    GO:0060754    positive regulation of mast cell chemotaxis    Any process that increases the rate, frequency or extent of mast cell chemotaxis. Mast cell chemotaxis is the movement of a mast cell in response to an external stimulus.
    GO:0002052    positive regulation of neuroblast proliferation    Any process that activates or increases the rate of neuroblast proliferation.
    GO:0050731    positive regulation of peptidyl-tyrosine phosphorylation    Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
    GO:0031954    positive regulation of protein autophosphorylation    Any process that activates or increases the frequency, rate or extent of the phosphorylation by a protein of one or more of its own residues.
    GO:0050714    positive regulation of protein secretion    Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
    GO:0030947    regulation of vascular endothelial growth factor receptor signaling pathway    Any process that modulates the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.
    GO:0042493    response to drug    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
    GO:0007165    signal transduction    The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
    GO:0006929    substrate-dependent cell migration    The orderly movement of a cell from one site to another along a substrate such as the extracellular matrix; the migrating cell forms a protrusion that attaches to the substrate.
    GO:0048010    vascular endothelial growth factor receptor signaling pathway    Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
cellular component
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0031093    platelet alpha granule lumen    The volume enclosed by the membrane of the platelet alpha granule.

Chain L,M,N,O   (VGFR2_HUMAN | P35968)
molecular function
    GO:0005524    ATP binding    Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
    GO:0051879    Hsp90 protein binding    Interacting selectively and non-covalently with Hsp90 proteins, any of a group of heat shock proteins around 90kDa in size.
    GO:0019838    growth factor binding    Interacting selectively and non-covalently with any growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate.
    GO:0005178    integrin binding    Interacting selectively and non-covalently with an integrin.
    GO:0016301    kinase activity    Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
    GO:0000166    nucleotide binding    Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0004672    protein kinase activity    Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
    GO:0004713    protein tyrosine kinase activity    Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
    GO:0004716    signal transducer, downstream of receptor, with protein tyrosine kinase activity    Conveys a signal from an upstream receptor or intracellular signal transducer by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
    GO:0016740    transferase activity    Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
    GO:0004714    transmembrane receptor protein tyrosine kinase activity    Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
    GO:0038085    vascular endothelial growth factor binding    Interacting selectively and non-covalently with a vascular endothelial growth factor.
    GO:0005021    vascular endothelial growth factor-activated receptor activity    Combining with a vascular endothelial growth factor (VEGF) and transmitting the signal across the plasma membrane to initiate a change in cell activity.
biological process
    GO:0001525    angiogenesis    Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
    GO:0035584    calcium-mediated signaling using intracellular calcium source    A series of molecular signals in which a cell uses calcium ions released from an intracellular store to convert a signal into a response.
    GO:0030154    cell differentiation    The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
    GO:0002042    cell migration involved in sprouting angiogenesis    The orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels involved in sprouting angiogenesis.
    GO:0035924    cellular response to vascular endothelial growth factor stimulus    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus.
    GO:0035162    embryonic hemopoiesis    The stages of blood cell formation that take place within the embryo.
    GO:0003158    endothelium development    The process whose specific outcome is the progression of an endothelium over time, from its formation to the mature structure. Endothelium refers to the layer of cells lining blood vessels, lymphatics, the heart, and serous cavities, and is derived from bone marrow or mesoderm. Corneal endothelium is a special case, derived from neural crest cells.
    GO:0030198    extracellular matrix organization    A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
    GO:0007275    multicellular organism development    The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
    GO:0043066    negative regulation of apoptotic process    Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
    GO:2000352    negative regulation of endothelial cell apoptotic process    Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
    GO:0038083    peptidyl-tyrosine autophosphorylation    The phosphorylation by a protein of one or more of its own tyrosine amino acid residues, or a tyrosine residue on an identical protein.
    GO:0018108    peptidyl-tyrosine phosphorylation    The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
    GO:0016310    phosphorylation    The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
    GO:0070374    positive regulation of ERK1 and ERK2 cascade    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
    GO:0043410    positive regulation of MAPK cascade    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.
    GO:0045766    positive regulation of angiogenesis    Any process that activates or increases angiogenesis.
    GO:0030335    positive regulation of cell migration    Any process that activates or increases the frequency, rate or extent of cell migration.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:0038033    positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway    A series of molecular signals initiated by the binding of a vascular endothelial growth factor (VEGF) to a VEGFR on the surface of a cell, which activates or increases the frequency, rate or extent of endothelial cell chemotaxis.
    GO:0010595    positive regulation of endothelial cell migration    Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
    GO:0001938    positive regulation of endothelial cell proliferation    Any process that activates or increases the rate or extent of endothelial cell proliferation.
    GO:0051894    positive regulation of focal adhesion assembly    Any process that activates or increases the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions.
    GO:0016239    positive regulation of macroautophagy    Any process, such as recognition of nutrient depletion, that activates or increases the rate of macroautophagy to bring cytosolic macromolecules to the vacuole/lysosome for degradation.
    GO:0051901    positive regulation of mitochondrial depolarization    Any process that activates, maintains or increases the frequency, rate or extent of the change in the membrane potential of the mitochondria from negative to positive.
    GO:0090141    positive regulation of mitochondrial fission    Any process that increases the rate, frequency or extent of mitochondrial fission. Mitochondrial fission is the division of a mitochondrion within a cell to form two or more separate mitochondrial compartments.
    GO:0051770    positive regulation of nitric-oxide synthase biosynthetic process    Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of a nitric oxide synthase enzyme.
    GO:0014068    positive regulation of phosphatidylinositol 3-kinase signaling    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
    GO:0050927    positive regulation of positive chemotaxis    Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
    GO:0001934    positive regulation of protein phosphorylation    Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
    GO:2001214    positive regulation of vasculogenesis    Any process that activates or increases the frequency, rate or extent of vasculogenesis.
    GO:0046777    protein autophosphorylation    The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
    GO:0006468    protein phosphorylation    The process of introducing a phosphate group on to a protein.
    GO:0008360    regulation of cell shape    Any process that modulates the surface configuration of a cell.
    GO:0023014    signal transduction by protein phosphorylation    A process in which the transfer of one or more phosphate groups to a substrate transmits a signal to the phosphorylated substrate.
    GO:0007169    transmembrane receptor protein tyrosine kinase signaling pathway    A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0048010    vascular endothelial growth factor receptor signaling pathway    Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0001570    vasculogenesis    The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes.
    GO:0016032    viral process    A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.
cellular component
    GO:0005794    Golgi apparatus    A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
    GO:0030054    cell junction    A cellular component that forms a specialized region of connection between two or more cells or between a cell and the extracellular matrix. At a cell junction, anchoring proteins extend through the plasma membrane to link cytoskeletal proteins in one cell to cytoskeletal proteins in neighboring cells or to proteins in the extracellular matrix.
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0031410    cytoplasmic vesicle    A vesicle found in the cytoplasm of a cell.
    GO:0005769    early endosome    A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.
    GO:0005783    endoplasmic reticulum    The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
    GO:0005768    endosome    A vacuole to which materials ingested by endocytosis are delivered.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005887    integral component of plasma membrane    The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0045121    membrane raft    Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
    GO:0005634    nucleus    A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0097443    sorting endosome    A multivesicular body surrounded by and connected with multiple tubular compartments with associated vesicles.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    BMA  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    CS  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    NAG  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
    AC7  [ RasMol ]  +environment [ RasMol ]
    AC8  [ RasMol ]  +environment [ RasMol ]
    AC9  [ RasMol ]  +environment [ RasMol ]
    BC1  [ RasMol ]  +environment [ RasMol ]
    BC2  [ RasMol ]  +environment [ RasMol ]
    BC3  [ RasMol ]  +environment [ RasMol ]
    BC4  [ RasMol ]  +environment [ RasMol ]
    BC5  [ RasMol ]  +environment [ RasMol ]
    BC6  [ RasMol ]  +environment [ RasMol ]
    BC7  [ RasMol ]  +environment [ RasMol ]
    BC8  [ RasMol ]  +environment [ RasMol ]
    BC9  [ RasMol ]  +environment [ RasMol ]
    CC1  [ RasMol ]  +environment [ RasMol ]
    CC2  [ RasMol ]  +environment [ RasMol ]
    CC3  [ RasMol ]  +environment [ RasMol ]
    CC4  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Arg L:164 - Tyr L:165   [ RasMol ]  
    Arg M:164 - Tyr M:165   [ RasMol ]  
    Arg N:164 - Tyr N:165   [ RasMol ]  
    Arg O:164 - Tyr O:165   [ RasMol ]  
    Gln N:280 - Ser N:281   [ RasMol ]  
    Ile L:138 - Thr L:139   [ RasMol ]  
    Lys A:153 - Pro A:154   [ RasMol ]  
    Lys B:153 - Pro B:154   [ RasMol ]  
    Lys C:153 - Pro C:154   [ RasMol ]  
    Lys D:153 - Pro D:154   [ RasMol ]  
    Ser L:229 - Pro L:230   [ RasMol ]  
    Ser M:229 - Pro M:230   [ RasMol ]  
    Ser N:229 - Pro N:230   [ RasMol ]  
    Ser O:123 - Pro O:124   [ RasMol ]  
    Ser O:229 - Pro O:230   [ RasMol ]  
    Tyr L:165 - Pro L:166   [ RasMol ]  
    Tyr M:165 - Pro M:166   [ RasMol ]  
    Tyr N:165 - Pro N:166   [ RasMol ]  
    Tyr O:165 - Pro O:166   [ RasMol ]  
    Val A:190 - Pro A:191   [ RasMol ]  
    Val B:190 - Pro B:191   [ RasMol ]  
    Val C:190 - Pro C:191   [ RasMol ]  
    Val D:190 - Pro D:191   [ RasMol ]  
    Val O:219 - Gly O:220   [ RasMol ]  
 
Biological Units
  Complete Structure
    Biological Unit 1  [ Jena3D ]
    Biological Unit 2  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  2x1w
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  VEGFC_HUMAN | P49767
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
  VGFR2_HUMAN | P35968
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  (no 'MIM ID' available)
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  VEGFC_HUMAN | P49767
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)
  VGFR2_HUMAN | P35968
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        VEGFC_HUMAN | P497672x1x 4bsk
        VGFR2_HUMAN | P359681vr2 1y6a 1y6b 1ywn 2m59 2met 2meu 2oh4 2p2h 2p2i 2qu5 2qu6 2rl5 2x1x 2xir 3b8q 3b8r 3be2 3c7q 3cjf 3cjg 3cp9 3cpb 3cpc 3dtw 3efl 3ewh 3kvq 3s35 3s36 3s37 3u6j 3v2a 3v6b 3vhe 3vhk 3vid 3vnt 3vo3 3wzd 3wze 4ag8 4agc 4agd 4asd 4ase 5ew3

(-) Related Entries Specified in the PDB File

1vr2 HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN
1y6a CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR
1y6b CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR
1ywn VEGFR2 IN COMPLEX WITH A NOVEL 4-AMINO- FURO[2,3-D]PYRIMIDINE
2x1x CRYSTAL STRUCTURE OF VEGF-C IN COMPLEX WITH DOMAINS 2 AND 3 OF VEGFR2 IN A TETRAGONAL CRYSTAL FORM